Biddle Warner Weston has filed 4 insider transactions across 1 company since April 2024.
Most recent transaction: a grant/award of 58000 shares of Kyverna Therapeutics, Inc. ($KYTX) on March 13, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | Kyverna Therapeutics, Inc. | $KYTX | Biddle Warner Weston | Chief Executive Officer | A | Common Stock | 58000 | $0.00 | 58,000.0000 | 43,796,170 | 9999.99% | 0.13% |
| March 13, 2026 | Kyverna Therapeutics, Inc. | $KYTX | Biddle Warner Weston | Chief Executive Officer | A | Stock Option (right to buy) | 350000 | $0.00 | 350,000.0000 | 43,796,170 | 9999.99% | 0.80% |
| April 11, 2024 | Kyverna Therapeutics, Inc. | $KYTX | Biddle Warner Weston | Chief Executive Officer | A | Stock Option (right to buy) | 332500 | $0.00 | 332,500.0000 | 0 | 9999.99% | 0.00% |
| Sept. 16, 2024 | Kyverna Therapeutics, Inc. | $KYTX | Biddle Warner Weston | Chief Executive Officer | A | Stock Option (right to buy) | 2579259 | $0.00 | 2,579,259.0000 | 0 | 9999.99% | 0.00% |